Induced pluripotent stem (iPS) cells from human fetal stem cells.

Area of Science:

• Stem cell biology
• Developmental biology
• Regenerative medicine

Background:

• Pluripotency is the capacity of stem cells to differentiate into all cell types and self-renew.
• Induced pluripotent stem cells (iPS cells) are somatic cells reprogrammed to an embryonic stem cell-like state.
• Fetal tissues offer a source for generating pluripotent cells.

Purpose of the Study:

• To discuss the use of fetal tissues, specifically human amniotic fluid stem cells, for cell reprogramming.
• To explore the development and implications of chemical reprogramming.
• To evaluate the pros and cons of deriving pluripotent cells from fetal sources for clinical applications.

Main Methods:

• Ectopic expression of transcription factors for cell reprogramming.
• Modulation of culture conditions and small molecule supplementation for chemical reprogramming.
• Derivation and characterization of stem cells from human amniotic fluid.

Main Results:

• Fetal tissues, including amniotic fluid, can be utilized for generating pluripotent stem cells.
• Chemical reprogramming offers an alternative method for inducing pluripotency.
• Advantages and disadvantages of using fetal-derived pluripotent cells are identified.

Conclusions:

• Reprogramming fetal tissues, especially from amniotic fluid, is a viable strategy for generating pluripotent stem cells.
• Chemical reprogramming presents a promising avenue for therapeutic applications.
• Careful consideration of the benefits and drawbacks is necessary for the clinical translation of fetal-derived pluripotent cells.